Synthetic Absorbable Sutures Market
Report ID: SQMIG35B2405
Report ID: SQMIG35B2405
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35B2405 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
147
|Figures:
78
Global Synthetic Absorbable Sutures Market size was valued at USD 2.64 Billion in 2024 and is poised to grow from USD 2.88 Billion in 2025 to USD 5.73 Billion by 2033, growing at a CAGR of 9.0% during the forecast period (2026-2033).
The global synthetic absorbable sutures market comprises polymer‑based threads designed to dissolve after tissue healing, offering clinicians an alternative to traditional non‑absorbable materials. With the rise of minimally invasive surgeries, it forced medical professionals to find sutures that offer high tensile resistance while providing the advantage of not having to remove them afterwards. Since the early 2000s, manufacturers introduced polyglycolic acid and poly‑glactin monofilaments, reducing inflammation and infection rates compared with catgut. This evolution was driven by regulatory support for bio‑compatible devices and by patient preference for faster recovery. Consequently, hospitals worldwide have increasingly adopted absorbable options, reinforcing the market’s relevance in surgical practice across continents.
The principal growth catalyst for synthetic absorbable sutures lies in the rising prevalence of chronic wounds and diabetic complications, which compel clinicians to select materials that promote tissue regeneration while avoiding foreign‑body reactions. When a suture degrades into by‑products, inflammatory responses diminish, accelerating healing and lowering readmission rates; hospitals experience cost savings and better patient outcomes. This cause effect relationship has spurred investment in polymers such as polydioxanone, enabling surgeons to perform laparoscopic bowel anastomoses with reduced scar formation. Additionally, markets in Asia‑Pacific are expanding procurement budgets, creating opportunities for manufacturers to launch kits that integrate drug‑coated threads for antimicrobial protection.
How is AI-Driven Automation Influencing the Synthetic Absorbable Sutures Market?
Automation powered by artificial intelligence is transforming the market for synthetic absorbable sutures through the optimization of design, manufacturing and quality control processes. While machine learning algorithms focus on evaluating polymer traits and advising on optimal formulations, robotics assures superior quality workmanship. The benefit of automated quality control is that it allows for the immediate identification of any potential defects. Additionally, adaptive maintenance helps work out the various strategies Cz and thus reduces the downtimeof the equipment, thereby ensuring a continuous product supply. Furthermore, technology enables the customization of the characteristics in accordance with the surgeon’s requirements.
In June 2025, Johnson & Johnson MedTech, parent company of Ethicon, launched the Polyphonic™ AI Fund for Surgery to accelerate AI innovation across the surgical ecosystem. The initiative supports AI-powered workflow optimization, surgical decision-making, and operating room efficiency, indirectly advancing outcomes for procedures utilizing synthetic absorbable sutures.
Market snapshot - (2026-2033)
Global Market Size
USD 2.64 Billion
Largest Segment
Polyglactin 910 (Vicryl)
Fastest Growth
Other Synthetic Polymers
Growth Rate
9.0% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global synthetic absorbable sutures market is segmented by material, product type, coating, application, end user and region. Based on material, the market is segmented into polyglactin 910 (vicryl), poliglecaprone 25 (monocryl), polydioxanone (PDS), polyglycolic acid (dexon) and other synthetic polymers. Based on product type, the market is segmented into monofilament and multifilament (braided). Based on coating, the market is segmented into coated, uncoated and antimicrobial coated. Based on application, the market is segmented into general surgery, orthopedic surgery, gynecology, cardiovascular surgery and plastic & reconstructive surgery. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Polyglactin 910 segment dominates because it offers reliable tensile strength, predictable absorption rates, and easy handling, making it a preferred choice for a wide range of procedures. The history of its clinical performance helps the surgical staff in making their decisions, while the low cost contributes to its inclusion in hospital formularies. The combination of these features allows it to maintain its leadership in the sphere of absorbable synthetic sutures. Besides, the possibility of using both monofilament and multifilament versions of the product opens up new opportunities for manufacturers, as they can develop product line adaptable for the needs of any surgery.
However, polydioxanone segment is witnessing the strongest growth momentum because its prolonged absorption profile matches rising demand for sutures that provide extended wound support. Emerging minimally invasive techniques and material engineering expand its clinical utility, prompting manufacturers to develop advanced coatings and specialty formulations that accelerate market expansion and create new opportunities.
General surgery application segment leads because it encompasses the highest volume of procedures, creating relentless demand for adaptable suturing solutions. Ease of use and reliability in knot securing, as well as anticipated degradation are high priorities among surgeons. This provides manufacturers with a motivation to improve their sutures performance for different types of tissues. Moreover, the pursuit of faster healing and less tissue scarring encourages the development of sutures with the best absorption and strength properties, helping the company to remain a leader in this industry.
Meanwhile, cardiovascular surgery application emerges as the key high growth area because novel minimally invasive cardiac procedures increasingly rely on sutures that combine high tensile strength with controlled absorption. Innovations in polymer blends and bioactive coatings are expanding suitability for delicate vascular repairs, attracting investment and accelerating market expansion opportunities.
To get detailed segments analysis, Request a Free Sample Report
The region combines a sizable and rapidly expanding patient base with accelerating adoption of advanced surgical techniques. The increasing focus on investments in healthcare infrastructure and minimally invasive surgery has led to the rise in demand for high-performance absorbable sutures. A robust local production base, supported by research and development capabilities of companies, which are likely to have collaborations with universities, allows for faster product development plans. The low-cost production and a highly skilled medical professionals’ workforce improves market access in developed and developing economies. Moreover, efficient regulations guarantee fast product approval in order for regional players to occupy a market niche and keep the advantage over global competitors.
Synthetic absorbable sutures market in Japan reflects a mature healthcare ecosystem with a strong focus on surgical precision and patient safety. Local producers have developed several research and development networks as well as high standards of quality, resulting in making a name for themselves as reliable producers. The existing reimbursement programs aimed at promoting cost-effective procedures enable further development of the industry and encourage the introduction of new innovations.
Synthetic absorbable sutures market in South Korea benefits from a technologically driven medical sector and aggressive government support for biotech initiatives. The demand for high-quality sutures will continue growing due to urbanization and the aging population, which will lead to an increase in surgical procedures. Partnership between hospitals and local manufacturers fosters product development in accordance with local standards. Favorable national regulations and the commitment to minimally invasive methods contribute to the market growth.
The North American landscape is characterized by a sophisticated clinical environment where surgeons prioritize outcomes that reduce postoperative complications. A huge importance on research and continuous product enhancement drives taking on sutures with improved handling and reliable absorption characteristics. Healthcare insurers are placing more emphasis on value-based healthcare that rewards technologies which help shorten hospital stays and minimize chances of infection. Due to comprehensive insurance coverage and good distribution systems, entry to market goes smooth. The region also has a culture of introducing new innovations into medical technology, which is enforced through strict regulatory policies.
Synthetic absorbable sutures market in the United States is propelled by leading academic medical centers that champion minimally invasive surgery and evidence‑based practice. Extensive clinical trial infrastructure facilitates swift evaluation of new suture materials, encouraging early market entry. Integrated supply chains and efficient purchasing coalitions are driving the procurement process, while educational programs for doctors highlight the clinical advantages of modern stitches.
Synthetic absorbable sutures market in Canada reflects a healthcare system focused on universal access and high standards of patient care. Joint research projects among hospitals and biotechnology companies facilitate the progress of localized technology validation. Provincial health authorities advocate for the introduction of technologies that reduce complications, as these technologies would be in line with chronic goals of sustainable healthcare delivery.
European markets are leveraging integrated regulatory harmonization and a strong tradition of medical innovation to enhance their standing. Collaborative research and manufacturing partnerships across borders foster the acceleration of the design of sutures meeting high requirements in terms of safety and performance. Policies prioritizing efforts to achieve effective patient outcomes lead to a preference for absorbable products minimizing the necessity for re-intervention whenever possible. Good clinical training and a well-established network of specialty hospitals facilitate the implementation of advanced suture technologies. Moreover, environmental responsibility contributes to the implementation of biodegradable products which meets the increasing demand for sustainable medical practices in Europe.
Synthetic absorbable sutures market in Germany is underpinned by a robust engineering tradition and a highly regulated medical environment. Prominent research institutes collaborate with companies to perfect suture qualities focusing on tensile strength and absorption rate. Hospital systems pursue lower costs while ensuring quality, boosting the need for dependable absorbable products. Reimbursement systems that motivate physicians to use the best suturing techniques complicate reimbursement systems that reward lower complication rates.
Synthetic absorbable sutures market in the United Kingdom benefits from a centralized health service that emphasizes evidence‑based procurement. National guidelines encourage the use of sutures that support faster healing and lower infection risk. Partnerships between surgeons and companies producing surgical devices lead to constant product improvement according to the distinct local practices. Efforts aimed at improving surgery results are synchronized with the market development and strengthening Britain's position in determining the norms of the sector.
Synthetic absorbable sutures market in France is shaped by a healthcare system that values clinical efficacy and patient comfort. Long surgical training programs push for early use of sutures with expected performances. Cooperation between French biotechnological enterprises and companies from other countries support innovations, whereas public health strategies that encourage a reduction in the costs of surgical recovery promote the use of absorbable solutions.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Surgical Procedure Volume
Advancements In Bioabsorbable Material Science
Higher Cost Compared To Traditional Sutures
Regulatory Hurdles In Emerging Markets
Request Free Customization of this report to help us to meet your business objectives.
The global synthetic absorbable sutures market is moderately consolidated, with leading companies competing through product innovation, antimicrobial technologies, regulatory approvals, and geographic expansion. The key players in the global market include firms such as Ethicon (Johnson & Johnson), Medtronic plc, B. Braun Melsungen AG, Smith+Nephew plc, Corza Medical, Healthium Medtech, and Teleflex Incorporated among others. They invest a lot in innovative technologies and development of polymeric thread materials, knot-free solutions, and wound infection resistant coatings, besides different collaboration programs with hospitals.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis the global synthetic absorbable sutures market is being propelled primarily by the rising volume of surgical procedures, especially minimally invasive operations that demand reliable, bio‑compatible closure. A second catalyst is rapid progress in polymer chemistry which is delivering sutures with higher tensile strength and tailored absorption rates, widening clinical acceptance. The market’s growth is tempered by the higher cost of these advanced sutures relative to conventional options, limiting adoption in price‑sensitive settings. Asia Pacific currently dominates the market thanks to its expanding patient base, strong infrastructure investment and cost‑effective manufacturing. Within the product mix Polyglactin 910 remains the leading segment because of its proven performance and broad surgeon confidence.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.64 Billion |
| Market size value in 2033 | USD 5.73 Billion |
| Growth Rate | 9.0% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Synthetic Absorbable Sutures Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Synthetic Absorbable Sutures Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Synthetic Absorbable Sutures Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Synthetic Absorbable Sutures Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Synthetic Absorbable Sutures Market size was valued at USD 2.64 Billion in 2024 and is poised to grow from USD 2.88 Billion in 2025 to USD 5.73 Billion by 2033, growing at a CAGR of 9.0% during the forecast period (2026-2033).
The synthetic absorbable sutures market is dominated by Medtronic, Johnson & Johnson, Boston Scientific, Smith & Nephew and B. Braun, each intensifying competition through expanded product portfolios and ongoing polymer‑technology R&D, while strategic collaborations with hospital networks and acquisition of niche material specialists sharpen their market positioning. 'Ethicon Inc. (Johnson & Johnson)', 'B. Braun Melsungen AG', 'Medtronic plc', 'Smith & Nephew plc', 'Surgical Specialties Corporation', 'Peters Surgical', 'Healthpoint Biotherapeutics', 'Demophobus Ltd.', 'Z-Medica (QuikClot)', 'Lookout Medical Products', 'Taeyoung', 'Mani Inc.', 'Huaiyin Micra Medical', 'Look Sutures', 'Serag-Wiessner GmbH', 'Unimed Products', 'Cardinal Health', 'Medline Industries', 'Owens & Minor', 'Stratpharma AG'
The rising number of minimally invasive and complex surgeries creates a demand for suture materials that provide reliable tissue approximation while minimizing postoperative complications. Synthetic absorbable sutures meet these clinical requirements through predictable degradation profiles and reduced infection risk, encouraging surgeons to select them over traditional options. Consequently, hospitals and clinics are integrating these sutures into standard protocols, which fuels broader market adoption and drives sustained growth across geographic regions. Such evidence strengthens clinician confidence and accelerates product uptake globally.
Innovative Materials Driving Adoption: Manufacturers are accelerating the development of next‑generation polymers that combine faster absorption with enhanced tensile strength, enabling surgeons to achieve reliable wound closure while reducing tissue reaction. These materials also allow for customized degradation profiles tailored to specific surgical procedures, expanding clinical acceptance across orthopedics, cardiovascular and cosmetic applications. As a result, hospitals are increasingly specifying absorbable solutions in procurement policies, viewing them as strategic assets that improve patient turnover and reduce postoperative complications supporting overall cost‑effectiveness goals for providers
Why does Asia Pacific Dominate the Global Synthetic Absorbable Sutures Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
